Sleep and Alzheimer’s Biomarker Changes
Can improving sleep change Alzheimer’s-related biomarkers, beyond the observed association between sleep and beta-amyloid pathology?
Following this research could clarify whether sleep is merely associated with Alzheimer’s-related biological changes or offers a way to influence them. Biomarker changes would still need to be distinguished from benefits to memory or cognition.
Where it stands now
Main bottleneck
The bounded records do not establish whether improving sleep causes biomarker changes; the central barrier is moving from association to controlled evidence of an effect.
Watch next
Reported results comparing an intervention that improves sleep with a control group, showing whether Alzheimer’s-related biomarkers change alongside sleep.
Progress timeline
How the evidence has changed over time.
2026 · 1 update
- How BioFINDER-Sleep will connect sleep symptoms with Parkinson’s over timeResearch note 3 of 3 · Source date 2026-04-16
Since the previous research note · Earlier expectation not tested
Track continuity
Since the previous research note: A planned supplement trial will examine sleep and thinking in mild cognitive impairment
Previous expectation: A supplement might improve sleep and thinking in people with mild cognitive impairment if controlled research demonstrated sustained benefit and acceptable safety.
What this study adds: BioFINDER-Sleep describes a longitudinal investigation connecting confirmed REM sleep behavior disorder with biological and clinical changes in early Parkinson's disease and isolated REM sleep behavior disorder. It provides a distinct study-design milestone for investigating prognosis, without testing the earlier supplement expectation.
Current research note
2023 · 1 update
- A planned supplement trial will examine sleep and thinking in mild cognitive impairmentResearch note 2 of 3 · Source date 2023-09-08
Since the previous research note · Earlier expectation not tested
Track continuity
Since the previous research note: Associations between sleep and amyloid deposits varied by brain region in older adults
Previous expectation: Improving nighttime sleep might eventually reduce amyloid accumulation and preserve cognition before symptoms appear.
What this study adds: The current registry describes a planned citicoline-versus-placebo pilot assessing sleep, cognition and Alzheimer’s-related biomarkers in people with mild cognitive impairment. This introduces a supplement intervention in a different clinical population, but the supplied evidence does not test the earlier forecast with reported outcomes.
Current research note
2021 · 1 update
- Associations between sleep and amyloid deposits varied by brain region in older adultsResearch note 1 of 3 · Source date 2021-07-01
How this Track works
This page changes as new evidence arrives. Open any update to see what researchers found at that point in the story.